4//SEC Filing
de Verneuil Vanina 4
Accession 0001628280-25-007690
CIK 0001706431other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:34 PM ET
Size
8.6 KB
Accession
0001628280-25-007690
Insider Transaction Report
Form 4
de Verneuil Vanina
EVP and General Counsel
Transactions
- Award
Common Stock
2025-02-22+35,000→ 91,973 total - Sale
Common Stock
2025-02-24$9.45/sh−5,140$48,590→ 86,833 total - Award
Stock Option (Right to Buy)
2025-02-22+70,000→ 70,000 totalExercise: $9.57Exp: 2035-02-21→ Common Stock (70,000 underlying)
Footnotes (3)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F3]25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0002036234
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:34 PM ET
- Size
- 8.6 KB